首页 > 市场调查报告书 > 医疗设备

病患监测行动医疗

市场调查报告书

商品编码

1629830

全球穿戴式医疗设备市场 - 2024-2031

Global Wearable Medical Devices Market - 2024-2031

出版日期: 2024年12月30日 | 出版商:

DataM Intelligence | 英文 176 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

简介目录

2023年，全球穿戴式医疗设备市场规模达357亿美元，预计2031年将达2,074.7亿美元，2024-2031年预测期间复合年增长率为24.6%。

穿戴式医疗设备是医疗保健技术的重大进步，旨在即时监控健康指标。这些设备，从健身追踪器到心电图贴片等专用监视器，可提供有价值的健康见解并促进远端患者监测，特别是在服务不足的地区。收集的资料可以直接传输给医疗保健提供者，从而增强临床决策并可能改善患者的治疗结果。然而，穿戴式医疗设备的快速普及引起了人们对使用者接受度、安全性和道德影响的担忧。解决这些问题对于充分发挥其在现代医疗保健系统中的潜力至关重要。预计该市场将产生可观的收入。

市场动态：

驱动程式和限制

慢性病盛行率不断上升和健康意识增强

由于多种因素，全球使用的穿戴式医疗设备正在蓬勃发展，需求不断增加；其中之一是糖尿病、心血管疾病、呼吸系统疾病等慢性疾病的盛行率不断上升，需要持续监测和主动管理，而穿戴式装置可以轻鬆满足这项需求。举例来说，糖尿病患者的血糖监测设备、心血管健康的心率监测设备；这些正在成为主要产品。此外，消费者健康意识的增强进一步促使穿戴式科技用于预防性护理。

世界各地的政府和医疗机构都在倡导使用这些设备来减少再入院率并改善患者的治疗效果。它们还因与数位健康平台和行动应用程式的即时资料追踪、分析和警报的关联而变得更具吸引力。

例如，根据美国疾病管制与预防中心的数据，美国有 1.29 亿人患有至少一种主要慢性疾病，包括心臟病、癌症、糖尿病、肥胖和高血压。美国十大死亡原因中有五个与可预防和可治疗的慢性病有关。在过去的二十年中，患病率稳步上升，并且预计这种趋势将持续下去。越来越多的美国人患有多种慢性病，其中 42% 的人患有两种或两种以上，12% 的人患有至少五种慢性病。慢性病也对美国医疗保健系统产生重大影响，占年度 4.1 兆美元支出的 90%。

这些设备，例如血糖监测仪、智慧手錶和健身追踪器，可以帮助患者和医疗保健提供者有效地管理这些状况。慢性病带来的经济负担占年度医疗保健支出的 90%，凸显了对具有成本效益的解决方案的需求。慢性病盛行率的上升以及对多功能穿戴装置的需求推动了全球的进步和市场扩张。

资料隐私和安全问题

由于资料隐私和安全问题，穿戴式医疗设备市场面临挑战。随着大量敏感健康资料的产生和传输，人们开始担心未经授权的存取、资料外洩和滥用个人健康资讯。网路安全威胁，特别是当设备透过物联网互连时，对用户信任构成挑战。各地区缺乏标准化监管使情况更加复杂。由于隐私问题，消费者对采用这些技术犹豫不决，这可能会减缓市场成长。公司面临越来越大的压力，需要投资强大的安全协议并遵守不断发展的法律框架。

Wearable medical devices are a significant advancement in healthcare technology, designed to monitor health metrics in real-time. These devices, ranging from fitness trackers to specialized monitors like ECG patches, provide valuable health insights and facilitate remote patient monitoring, especially in underserved areas. The data collected can be transmitted directly to healthcare providers, enhancing clinical decision-making and potentially improving patient outcomes. However, the rapid adoption of wearable medical devices raises concerns about user acceptance, security, and ethical implications. Addressing these issues is crucial for the full realization of their potential in modern healthcare systems. The market is projected to generate substantial revenue.

Market Dynamics: Drivers & Restraints

Growing Prevalence of Chronic Diseases and Health Awareness

Wearable medical devices used all over the world are highly prospering as their demand increases because of many factors; one of them is the incessantly growing prevalence of chronic diseases like diabetes, cardiovascular diseases, respiratory conditions, etc., which requires continuous monitoring and proactive management where wearable devices quite easily can cater to the need. To illustrate, glucose monitoring devices for diabetic patients, heart rate monitors for cardiovascular health; these are becoming staples. Also, increased health consciousness among consumers further induces the adoption of wearable technologies for preventive care.

Governments and healthcare organizations all over the world are advocating about these devices to reduce readmissions into hospitals and enhance patient outcomes. They also become more attractive with their association with digital health platforms and mobile applications for real-time data tracking, analysis, and alert.

For instance, according to Centers for Disease Control and Prevention, the US has 129 million people with at least one major chronic disease, including heart disease, cancer, diabetes, obesity, and hypertension. Five of the top 10 leading causes of death in the US are associated with preventable and treatable chronic diseases. Over the past two decades, prevalence has steadily increased, and this trend is expected to continue. An increasing proportion of Americans are dealing with multiple chronic conditions, with 42% having two or more and 12% having at least five. Chronic diseases also significantly impact the US healthcare system, accounting for 90% of annual $4.1 trillion expenditure.

These devices, such as glucose monitors, smartwatches, and fitness trackers, help patients and healthcare providers manage these conditions effectively. The financial burden of chronic diseases, accounting for 90% of annual healthcare expenditure, underscores the need for cost-effective solutions. The rising prevalence of chronic diseases and the need for multifunctional wearables drive advancements and market expansion worldwide.

Data Privacy and Security Concerns

The wearable medical device market faces challenges due to data privacy and security concerns. With the vast amount of sensitive health data generated and transmitted, concerns about unauthorized access, data breaches, and misuse of personal health information arise. Cybersecurity threats, particularly as devices become interconnected through IoT, pose a challenge to user trust. The lack of standardized regulations across regions further complicates the situation. Consumers are hesitant to adopt these technologies due to privacy concerns, potentially slowing market growth. Companies face increasing pressure to invest in robust security protocols and comply with evolving legal frameworks.

Segment Analysis

The global wearable medical devices market is segmented based on product type, application, end user and region.

Product type:

Diagnostic & Monitoring Devices segment is expected to dominate the wearable medical devices market share

The diagnostic & monitoring devices segment holds a major portion of the wearable medical devices market share and is expected to continue to hold a significant portion of the wearable medical devices market share during the forecast period.

The Global Wearable Medical Devices Market is certainly buoyed up and influencing the expansion and adoption of the various diagnostic and monitoring devices that feature prominently in it. Such devices are crafted, as the ultimate end purpose, for the real-time physiological and biometric data gathering to allow a continuous monitoring and early diagnosis of different health conditions.

Examples of such products include continuous glucose monitoring systems, ECG monitoring systems, pulse oximeters, and blood pressure monitoring systems. These systems are basically used for the management of most chronic conditions such as diabetes, cardiovascular diseases, and respiratory diseases. They enable the patients to keep a convenient and informative record of their own health metrics.

For instance, in October 2024, Samsung has launched the Galaxy Ring in India, a wearable device designed to enhance digital health through Galaxy AI. The sleek and compact device offers personalized health insights and tailored experiences. The Galaxy Ring is a significant step in active and autonomous health management, providing users with valuable guidance for healthier lifestyles. Its advanced sensors provide insights into users' lifestyle patterns, helping them manage their health goals.

Moreover, in June 2024, Elemind, a neurotech wellness company, has introduced a unique neurotechnology headband that enhances sleep performance by directing brainwaves out of wakeful patterns. The wearable device reduced the time to sleep in 76% of study participants by 48% and up to 74%.

Moreover, these enable healthcare providers to carry out the needed remoting of their patients leading to timely interventions and positive health outcomes. Advanced sensor-integrated, AI-driven analytics crammed in these devices will enhance the parameters while boosting their accuracy and predictive capability to provide actionable insight as well.

Application:

Remote Patient Monitoring segment is the fastest-growing segment in wearable medical devices market share

The remote patient monitoring segment is the fastest-growing segment in the wearable medical devices market share and is expected to hold the market share over the forecast period.

Remote Patient Monitoring is a fast-growing aspect of the global wearable medical devices market which needs lots of solutions regarding continuous work with healthcare access and management in places other than clinical environments. remote patient monitoring devices include wearable ECG monitors, glucose trackers, and respiratory sensors. It used to enable providers to monitor their patients' vital signs and chronic conditions in real time from anywhere. It mostly benefits elderly people, those whose mobility is challenged, and those suffering from chronic diseases that require frequent measurement by health care professionals. remote patient monitoring is a great growth opportunity for hospital readmissions, encourages patient engagement with the system, and provides early intervention in the event of abnormalities, which collectively improves health outcomes.

Moreover, rapid advancement of technologies such as telehealth applications and healthcare digitalization, along with the growing need for cost-effective solutions to reduce the burden on the healthcare systems, have significantly increased uptake of remote patient monitoring. this change in the trend will create a significant shift toward value-based care and make remote patient monitoring a critical and essential component of the growth seen in the global market for wearable medical devices.

Geographical Analysis

North America is expected to hold a significant position in the wearable medical devices market share

North America holds a substantial position in the wearable medical devices market and is expected to hold most of the market share.

North America is one of the prominent regions in the Global Wearable Medical Devices Market, and the following are the prime drivers for this. Chronic diseases such as diabetes, cardiovascular diseases, and obesity are prevalent in the region, giving rise to a considerable demand for such technologies where monitoring and management can be performed in real time. Rapid growth is also due to the higher adoption of digital health solutions and improved healthcare infrastructure. The high disposable income, along with the readiness of consumers to adopt advanced medical technologies, further push the use of such devices. Government initiatives to promote preventive healthcare and telemedicine encourage adoption as well.

For instance, in November 2024, Aktiia has launched its continuous blood pressure monitoring bracelet in Canada, marking its first market expansion outside Europe. The company's CEO, Raghav Gupta, praised Canada's collaborative healthcare environment for its ideal position to integrate innovative products. The launch aims to make it easier for millions of people to monitor their cardiovascular health, with smooth pathways for product adoption, clinical trials, and partnerships with healthcare providers across the country.

Europe is growing at the fastest pace in the wearable medical devices market

Europe holds the fastest pace in the wearable medical devices market and is expected to hold most of the market share due to the rise in chronic diseases like diabetes, cardiovascular conditions, and obesity, necessitating continuous health monitoring. The region's established healthcare infrastructure and high healthcare expenditure enable advanced wearable technologies adoption. The growing aging population and awareness of preventive healthcare support market growth. Favourable regulatory frameworks and increased investment in research contribute to innovation. Smartphone penetration and wireless connectivity have made it easier for patients and healthcare professionals to integrate wearable devices into their routines.

For instance, in June 2023, Lithuanian high-tech company Teltonika has launched TeltoHeart, a multifunctional smart medical wristband designed to help people with heart rhythm problems. The device, created by Arvydas Paukstys, was inspired by a highly accurate algorithm developed by Kaunas University of Technology and Vilnius University. Teltonika agreed to license this unique and patented technology, marking the beginning of a long road to developing a global gadget with exceptional technical capabilities.

Competitive Landscape

The major global players in the wearable medical devices market include Koninklijke Philips N.V.; Fitbit (Google); Garmin Ltd.; Medtronic; Omron; Withings; VitalConnect; Polar Electro; Sotera, Inc.; INVIZA Corporation; Dexcom, Inc.; GE HealthCare; CONTEC MEDICAL SYSTEMS CO., LTD; Nanowear Inc. among others.

Emerging Players

The emerging players in the wearable medical devices market include Nuubo, Activinsights Ltd, Intelesens Ltd , Polar Electro Oy and among others

Key Developments

In January 2024, Fitbit and Quest Diagnostics have partnered to study the use of wearable devices to improve metabolic health, which affects the risk of developing diseases like diabetes and heart disease. The Wearables for Metabolic Health (WEAR-ME) pilot study will combine behavioral and biometric data from Fitbit devices with Quest Diagnostics' laboratory tests to enhance metabolic health assessment and management, aiding disease prevention.
In April 2023, Garmin Ltd. has extended regional availability of its Dexcom Connect IQ apps, specifically designed for Type 1 or Type 2 diabetes users. These apps allow users to monitor glucose levels and trends on compatible smartwatches or cycling computers. The announcement is expected to impact the wearable medical devices market, enhancing accessibility to glucose monitoring solutions.

Why Purchase the Report?

Pipeline & Innovations: Reviews ongoing clinical trials, product pipelines, and forecasts upcoming advancements in medical devices and pharmaceuticals.
Product Performance & Market Positioning: Analyzes product performance, market positioning, and growth potential to optimize strategies.
Real-World Evidence: Integrates patient feedback and data into product development for improved outcomes.
Physician Preferences & Health System Impact: Examines healthcare provider behaviors and the impact of health system mergers on adoption strategies.
Market Updates & Industry Changes: Covers recent regulatory changes, new policies, and emerging technologies.
Competitive Strategies: Analyzes competitor strategies, market share, and emerging players.
Pricing & Market Access: Reviews pricing models, reimbursement trends, and market access strategies.
Market Entry & Expansion: Identifies optimal strategies for entering new markets and partnerships.
Regional Growth & Investment: Highlights high-growth regions and investment opportunities.
Supply Chain Optimization: Assesses supply chain risks and distribution strategies for efficient product delivery.
Sustainability & Regulatory Impact: Focuses on eco-friendly practices and evolving regulations in healthcare.
Post-market Surveillance: Uses post-market data to enhance product safety and access.
Pharmacoeconomics & Value-Based Pricing: Analyzes the shift to value-based pricing and data-driven decision-making in R&D.

The global wearable medical devices market report delivers a detailed analysis with 60+ key tables, more than 50 visually impactful figures, and 176 pages of expert insights, providing a complete view of the market landscape.

Target Audience 2023

Manufacturers: Pharmaceutical, Medical Device, Biotech Companies, Contract Manufacturers, Distributors, Hospitals.
Regulatory & Policy: Compliance Officers, Government, Health Economists, Market Access Specialists.
Component & Innovation: AI/Robotics Providers, R&D Professionals, Clinical Trial Managers, Pharmacovigilance Experts.
Investors: Healthcare Investors, Venture Fund Investors, Pharma Marketing & Sales.
Consulting & Advisory: Healthcare Consultants, Industry Associations, Analysts.
Supply Chain: Distribution and Supply Chain Managers.
Consumers & Advocacy: Patients, Advocacy Groups, Insurance Companies.
Academic & Research: Academic Institutions.

1. Methodology and Scope

1.1. Research Methodology
1.2. Research Objective and Scope of the Report

2. Definition and Overview

3. Executive Summary

3.1. Snippet by Product Type
3.2. Snippet by Application
3.3. Snippet by End User
3.4. Snippet by Region

4. Dynamics

4.1. Impacting Factors
- 4.1.1. Drivers
  - 4.1.1.1. Growing Prevalence of Chronic Diseases and Health Awareness
4.2. Restraints
4.3. Opportunity
- 4.3.1. Impact Analysis

5. Industry Analysis

5.1. Porter's Five Force Analysis
5.2. Supply Chain Analysis
5.3. Pricing Analysis
5.4. Regulatory Analysis

6. By Product type

6.1. Introduction
- 6.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product type
- 6.1.2. Market Attractiveness Index, By Product type
6.2. Diagnostic & Monitoring Devices*
- 6.2.1. Introduction
- 6.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
6.3. Therapeutic Devices

7. By Application

7.1. Introduction
- 7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
- 7.1.2. Market Attractiveness Index, By Application
7.2. Remote Patient Monitoring*
- 7.2.1. Introduction
- 7.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
7.3. Sports and Fitness Monitoring
7.4. Chronic Disease Management
7.5. Others

8. By End User

8.1. Introduction
- 8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
- 8.1.2. Market Attractiveness Index, By End User
8.2. Hospitals & Clinics*
- 8.2.1. Introduction
- 8.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
8.3. Homecare Settings
8.4. Ambulatory Care Centers
8.5. Fitness Centers and Sports Institutes

9. By Region

9.1. Introduction
- 9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
- 9.1.2. Market Attractiveness Index, By Region
9.2. North America
- 9.2.1. Introduction
- 9.2.2. Key Region-Specific Dynamics
- 9.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
- 9.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
- 9.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
- 9.2.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
  - 9.2.6.1. U.S.
  - 9.2.6.2. Canada
  - 9.2.6.3. Mexico
9.3. Europe
- 9.3.1. Introduction
- 9.3.2. Key Region-Specific Dynamics
- 9.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
- 9.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
- 9.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
- 9.3.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
  - 9.3.6.1. Germany
  - 9.3.6.2. U.K.
  - 9.3.6.3. France
  - 9.3.6.4. Spain
  - 9.3.6.5. Italy
  - 9.3.6.6. Rest of Europe
9.4. South America
- 9.4.1. Introduction
- 9.4.2. Key Region-Specific Dynamics
- 9.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
- 9.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
- 9.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
- 9.4.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
  - 9.4.6.1. Brazil
  - 9.4.6.2. Argentina
  - 9.4.6.3. Rest of South America
9.5. Asia-Pacific
- 9.5.1. Introduction
- 9.5.2. Key Region-Specific Dynamics
- 9.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
- 9.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
- 9.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
- 9.5.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
  - 9.5.6.1. China
  - 9.5.6.2. India
  - 9.5.6.3. Japan
  - 9.5.6.4. South Korea
  - 9.5.6.5. Rest of Asia-Pacific
9.6. Middle East and Africa
- 9.6.1. Introduction
- 9.6.2. Key Region-Specific Dynamics
- 9.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
- 9.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
- 9.6.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User

10. Competitive Landscape

10.1. Competitive Scenario
10.2. Market Positioning/Share Analysis
10.3. Mergers and Acquisitions Analysis

11. Company Profiles

11.1. Koninklijke Philips N.V*
- 11.1.1. Company Overview
- 11.1.2. Product Portfolio and Description
- 11.1.3. Financial Overview
- 11.1.4. Key Developments
11.2. Garmin Ltd
11.3. Medtronic
11.4. Omron
11.5. Withings
11.6. VitalConnect
11.7. Polar Electro
11.8. Sotera, Inc
11.9. INVIZA Corporation
11.10. GE HealthCare

LIST NOT EXHAUSTIVE